Step by step, together with your patient

Ionis Every StepTM is a support program dedicated to help your patient start and follow your prescribed treatment plan with DAWNZERA. Ionis Every Step offers a wide range of support and resources to meet your patient's needs at each step of their treatment journey:

Two Individuals Talking Icon

Patient Education Manager*

Your patient's primary Ionis Every Step partner who can explain product delivery, answer questions about DAWNZERA, provide educational resources, and more.

Health Shield Icon

Insurance navigation†

Assistance with the insurance approval process, including prior authorizations, appeals, and reauthorizations.

Health Insurance Card Icon

Affordability programs‡

Programs to help eligible patients afford their Ionis medication regardless of their insurance.

Computer Monitor Icon

DAWNZERA direct

An online companion that enables the option for you to prescribe and refill DAWNZERA, request a meeting with an Account Specialist, and track upcoming appointments. Reach out to your Account Specialist to learn more.

Wrench and Screwdriver Icon

Ongoing support

Resources to help your patients stay on track.

*Patient Education Managers do not provide clinical recommendations and will refer patients back to their health care providers as necessary.

†Insurance approval is not guaranteed. Ionis Every Step offers affordability programs for people prescribed DAWNZERA.

‡Terms and conditions apply. Programs subject to change or discontinue without notice, including in specific states.

IMPORTANT SAFETY INFORMATION & INDICATION

CONTRAINDICATIONS

DAWNZERA is contraindicated in patients with a history of serious hypersensitivity reactions, including anaphylaxis, to donidalorsen or any of the excipients in DAWNZERA.

WARNINGS AND PRECAUTIONS

Hypersensitivity Reactions
Hypersensitivity reactions, including anaphylaxis, have been reported in patients treated with DAWNZERA. If signs and symptoms of serious hypersensitivity reactions occur, discontinue DAWNZERA and institute appropriate therapy.

ADVERSE REACTIONS

Most common adverse reactions (incidence ≥ 5%) are injection site reactions, upper respiratory tract infection, urinary tract infection, and abdominal discomfort.

INDICATION

DAWNZERA (donidalorsen) is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.

Please see full Prescribing Information for DAWNZERA.